The Food and Drug Administration unveiled steps aimed at streamlining the approval process used for most medical devices and deferred decisions on the most contentious issues.
The FDA said Wednesday that it would ask the Institute of Medicine for input on seven proposals, including creation of a new class of devices that would require more data to win approval. Get the full story »
